Evidence map›Paper›PMID 28199696›Full record

ArticleNucleic acids research2017

Spartan deficiency causes accumulation of Topoisomerase 1 cleavage complexes and tumorigenesis.

Reeja S Maskey, Karen S Flatten, Cynthia J Sieben, Kevin L Peterson, Darren J Baker, Hyun-Ja Nam, Myoung Shin Kim, Thomas C Smyrk, Yusuke Kojima, Yuka Machida and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Reeja S MaskeyDepartment of Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Karen S FlattenDepartment of Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Cynthia J SiebenDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Kevin L PetersonDepartment of Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Darren J BakerDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Hyun-Ja NamDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Myoung Shin KimDepartment of Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Thomas C SmyrkDepartment of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Yusuke KojimaDepartment of Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Yuka MachidaDepartment of Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Annyoceli SantiagoDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Jan M van DeursenDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Scott H KaufmannDepartment of Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Yuichi J MachidaDepartment of Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Mayo Clinic · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Regulation of polymerase switching in translesion synthesisR01CA181178 · NCI · MAYO CLINIC ROCHESTER · PI MACHIDA, YUICHI · 2014 to 2018
$1.6M
NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA181178
6 · The paper itself

Abstract

Germline mutations in SPRTN cause Ruijs-Aalfs syndrome (RJALS), a disorder characterized by genome instability, progeria and early onset hepatocellular carcinoma. Spartan, the protein encoded by SPRTN, is a nuclear metalloprotease that is involved in the repair of DNA-protein crosslinks (DPCs). Although Sprtn hypomorphic mice recapitulate key progeroid phenotypes of RJALS, whether this model expressing low amounts of Spartan is prone to DPC repair defects and spontaneous tumors is unknown. Here, we showed that the livers of Sprtn hypomorphic mice accumulate DPCs containing Topoisomerase 1 covalently linked to DNA. Furthermore, these mice exhibited DNA damage, aneuploidy and spontaneous tumorigenesis in the liver. Collectively, these findings provide evidence that partial loss of Spartan impairs DPC repair and tumor suppression.

Indexed as

AneuploidyAnimalsCarcinogenesisCarcinoma, HepatocellularChromosomal Proteins, Non-HistoneDisease Models, AnimalDNA AdductsDNA-Binding ProteinsDNA Topoisomerases, Type IFemaleGene ExpressionHumansLiverLiver NeoplasmsMaleMiceChromosomal Proteins, Non-HistoneDNA AdductsDNA-Binding ProteinsDNA Topoisomerases, Type ISpartan protein, mouse

Identifiers

PMID28199696
PMCPMC5416836
OpenAlexW2588973931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.